09.05.25 -- Open Science And A Robust IP Strategy: Life Sciences Can Do Both

This year, registered CNS Summit participants gain access to exclusive hands-on learning experiences designed to help you grow, connect, and lead in a rapidly evolving industry. These opportunities include an AI Bootcamp & Certification, Community Calls to collaborate as a community, and Social Media Training to strengthen your online presence. If you wish to participate, please apply to join CNS Summit 2025, November 2-5.

Before you dive into clinical trials, ask yourself: Is my company operationally ready to handle the complexity that’s coming? Learn about five upgrades that can help you streamline operations and reduce risk.

This randomized controlled pivotal Phase 3 study evaluated efficacy and safety of neoadjuvant complex biologic administered for three consecutive weeks pre-surgery.

Review the challenges and intricacies of effectively delivering drugs to the lung and the advantages of using nanoparticles and gentle particle processing techniques to enable delivery of sensitive drugs.

Oncolytic viruses utilize a variety of viruses and vectors under current research and clinical trials. Learn more about the leading OV viruses and cell lines and how to strategize your OV production plan.

Explore how a partnership with UW–Madison and Genentech developed a breakthrough recycling technology that is poised to reshape single-use bioprocessing sustainability.

Discover compliant, on-site scientific staffing that ensures continuity, reduces HR burden, avoids co-employment risks, and outperforms temporary staffing in retention, cost savings, and operational efficiency.

Five key strategies are helping sponsors and CROs optimize their recruitment, leading to better use of time, reduced costs, increased capacity, and improved participant well-being.